Get started

Supportzones

$ARDX Support and ResistanceArdelyx shares are trading higher after Ladenburg Thalmann upgraded the stock from Neutral to Buy and announced a $6 price target. Also, Citigroup maintained a Buy rating and raised its price target from $7 to $13. Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California.
NASDAQ:ARDXLong
by BADQOMOCAWGOWLD
$VYNE Support and ResistanceHC Wainwright & Co. Assumes VYNE Therapeutics at Buy, Announces Price Target of $7 VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
NASDAQ:VYNELong
by BADQOMOCAWGOWLD
XAUUSD Trend analysis OANDA:XAUUSD Bullish Indications 1- Formation of HH & HL 2- Inverted hammer followed by big Green Candle 3- Major monthly Support zone around 1780 4- 4H trendline support 5- support at 0.786 Fib level 6- Double bottom 7- Confluence of Horizontal support + Fib Level + Trendline bounce 8- For last 7 years, December is green for 5 years, 1 year is neutral and 1 is little red. So I am long biased. Even if Gold continues downward trend, it may show bounce from major monthly support area and if bears appear to be much powerful than act according to plan B otherwise plan A will be intact. Both plans are mentioned on chart Please comment for any suggestion, follow and support if you like the idea. Thanks and good luck.
OANDA:XAUUSDLong
by yousufrz
BTC DAILY EMA CORRECTIONS + SUPPORT ZONE ANALYSISMacro support zones come from the WEEKLY chart Three outlooks for the BTC daily chart! Green Outlook 1) Bullish continuation of trend with a future pullback into the upper macro support zone. Red Outlook 2) A healthy bearish daily correction to the 25 & possibly wicking-off 50 EMA if volatile. This appears to be the logical observation, so I have labelled this as a short-term shorting analysis. Dark Red Outlook 3) Very bearish correction continues to the micro liquidity zone (41 - 44.5k estimated) ALL CONTENT IS EDUCATIONAL. NOT FINANCIAL ADVICE. DO YOUR OWN RESEARCH.
Short
by saerinox
$TEL : SHORT-MID TERM TARGETS (1-4H)Telcoin possibly approaching a decisive movement! Green bullish outlook: Push out of descending channel, successful retest off upper descending channel line, push past $0.02 then retest to confirm price breakout at the support zone (purple box), followed by a strong push to $0.03 (green dotted line) Yellow corrective outlook: Falling out of the support zone retesting at the $0.15 mark, then returning to and/or the lower ascending trend line Red bearish outlook: Failing the lower ascending trend line, with a bounce off the 21st July red wick (red dotted line) NOT FINANCIAL ADVICE, DO YOUR OWN RESEARCH, EDUCATIONAL PURPOSES ONLY
by saerinox
Support zone instead of simple support (Bitcoin fake breakouts)Sometimes just a simple line is not working and this is the time that zone gets its meaning. so instead of using so many lines, we can use <> and create some support and resistance zones instead of simple support and resistance. here take look at the Bitcoin example in previous weeks: But let's take look at the 30K support zone instead of the 30K support: and let's take look at Forex and the same scenario: here take look at the USDCAD example in the previous month: But let's take look at the 1.2060 support zone instead of the 1.2060 support: <<👍hope you enjoy👍 >>
BITSTAMP:BTCUSDEducation
by MMBTtrader
38
HD Triple Support Convergence1. Home Depot is nearing three distinct support indicators that converge at the 290.00-300.00 range. The 200 EMA, trend line from October 2019, and trend line from March 2020 all meet within the 290.00-300.00 range. Price currently sits above this range, and tested 300.00 in the previous few months. The three supports in this range should serve as a launch point for price, and price can retest the support before more upside. 2. The lower end of the support zone (290.00) was a notable resistance point on two different occasions during October 2020. Now it acts as a strong support, and price should hold on to this level with much strength. It is a good confirmation to the other trend lines. 3. Relative strength index shows a repeated pattern that has been followed by significant upside on two recent occasions. For RSI to reform this pattern, price needs to pull back to the support level and consolidate. After a confirmation of the support level and a reset of RSI, shares can move decisively to upside.
NYSE:HDLong
by desai0820
PLTR Testing Make or Break Supports1. Palantir is nearing a strong support zone (21.00-22.50) that it recently reclaimed. The support zone was reclaimed quickly after breaking, solidifying the strength at and beneath 21.00. Price just bounced at the top of the zone, yet I believe it will fall through to test the bottom of the support zone and consolidate within the zone briefly, reaffirming strength above 21.00. A powerful move to establish an uptrend could follow this confirmation and consolidation. Testing of 21.00 would also complete an inverse head and shoulders pattern. 2. Above the support zone, the next level is a 27.50 resistance. ARKW sold 13.1%. of their shares at this level last week. ARKW still holds a large majority of their shares and demonstrated good profit taking with the small sale, after purchasing upwards of 4 million shares in 2021. ARKW's sale caused some shake out of weak hands and brought shares down to the 22.50 support level. Shaking weak hands and ARK's aggressive bullish direction on PLTR are both good signs. 3. After some consolidation, I think shares can test the 27.50 resistance prior to August 12th earnings. After a test of 27.50 around earnings, a strong report could push shares above the resistance, and confirm that shares have re-entered an uptrend.
PLong
by desai0820